Clinical Trials Directory

Trials / Sponsors / Prothya Biosolutions

Prothya Biosolutions

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
CompletedDose-Response in PD and Safety of Cofact Under VKA Anticoagulation
Healthy Volunteers
Phase 1 / Phase 22021-11-12
TerminatedApotransferrin in Patients With β-thalassemia
β-thalassemia Intermedia
Phase 22019-03-21
CompletedPharmacokinetics of New HepBQuin
Healthy
Phase 12019-03-20
CompletedPharmacokinetics and Safety of IVIG Nanogam 100 mg/ml
Primary Immunodeficiency
Phase 32013-12-01
Active Not RecruitingApotransferrin in Atransferrinemia
Congenital Atransferrinemia
Phase 22010-12-01
CompletedIntravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
Myocardial Diseases, Parvovirus B19, Human
Phase 32009-11-01
CompletedTreatment of Deficient Subclass or Anti-polysaccharide Antibody Response
IgG Deficiency, Infections
Phase 42007-11-01
CompletedC1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
Angioedema
Phase 2 / Phase 32006-11-01
CompletedC1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
Angioedema
Phase 32006-02-01
CompletedKinetics, Efficacy and Safety of C1-Esteraseremmer-N
Hereditary Angioedema Type I, Angioneurotic Edema
Phase 22005-09-01
CompletedStudy on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutrope
MBL-Deficient, Neutropenia
Phase 22004-04-01
CompletedPost Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Hemophilia B
Phase 42003-05-01
CompletedStudy Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery
CPB, Oral Anticoagulant Therapy
Phase 42002-03-01
CompletedEfficacy and Safety of IVIG-L in ITP Patients
Purpura, Thrombocytopenic, Idiopathic
Phase 32001-10-01
CompletedKinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients
Hypogammaglobulinemia
Phase 2 / Phase 32001-05-01